These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
55 related items for PubMed ID: 8651920
1. The effect of hepatitis B virus X gene expression on response to growth inhibition by transforming growth factor-beta 1. Oshikawa O, Tamura S, Kawata S, Ito N, Tsushima H, Kiso S, Matsuda Y, Yamada A, Tamai S, Matsuzawa Y. Biochem Biophys Res Commun; 1996 May 24; 222(3):770-3. PubMed ID: 8651920 [Abstract] [Full Text] [Related]
2. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y, Kyprianou N. Cell Growth Differ; 1998 Feb 24; 9(2):185-93. PubMed ID: 9486855 [Abstract] [Full Text] [Related]
3. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells. Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K. J Cell Physiol; 1998 Jun 24; 175(3):305-13. PubMed ID: 9572475 [Abstract] [Full Text] [Related]
4. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells. Ghahary A, Tredget EE, Mi L, Yang L. Exp Cell Res; 1999 Aug 25; 251(1):111-20. PubMed ID: 10438576 [Abstract] [Full Text] [Related]
5. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. Fukuda M, Ikuta K, Yanagihara K, Tajima M, Kuratsune H, Kurata T, Sairenji T. Virology; 2001 Sep 15; 288(1):109-18. PubMed ID: 11543663 [Abstract] [Full Text] [Related]
6. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma. Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR, Salhab KF, McGrath P, Strodel W, Freeman JW. Anticancer Res; 2000 Sep 15; 20(1A):43-51. PubMed ID: 10769633 [Abstract] [Full Text] [Related]
7. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Joyce NC, Harris DL, Mello DM. Invest Ophthalmol Vis Sci; 2002 Jul 15; 43(7):2152-9. PubMed ID: 12091410 [Abstract] [Full Text] [Related]
8. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system. Ghahary A, Tredget EE, Shen Q. J Cell Physiol; 1999 Jul 15; 180(1):61-70. PubMed ID: 10362018 [Abstract] [Full Text] [Related]
9. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ. Cancer Res; 1997 Sep 15; 57(18):3929-34. PubMed ID: 9307274 [Abstract] [Full Text] [Related]
10. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition. Nishikawa Y, Wang M, Carr BI. J Cell Physiol; 1998 Sep 15; 176(3):612-23. PubMed ID: 9699514 [Abstract] [Full Text] [Related]
11. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors. Yoshizawa M, Miyazaki H, Kojima S. J Cell Physiol; 1998 Sep 15; 176(3):565-73. PubMed ID: 9699509 [Abstract] [Full Text] [Related]
12. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Kim SO, Park JG, Lee YI. Cancer Res; 1996 Aug 15; 56(16):3831-6. PubMed ID: 8706031 [Abstract] [Full Text] [Related]
13. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression. Mi Y, Borger DR, Fernandes PR, Pirisi L, Creek KE. Virology; 2000 May 10; 270(2):408-16. PubMed ID: 10793000 [Abstract] [Full Text] [Related]
14. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ, White RL, Matsunami N, Neufeld KL. Cancer Res; 2000 Dec 15; 60(24):6989-94. PubMed ID: 11156401 [Abstract] [Full Text] [Related]
15. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI. Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154 [Abstract] [Full Text] [Related]
16. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype. Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G. J Cell Physiol; 1997 Aug 15; 172(2):200-8. PubMed ID: 9258341 [Abstract] [Full Text] [Related]
17. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity. Hummer BT, Bartlett C, Henry E, Weissman BE. J Cell Physiol; 2003 Mar 15; 194(3):289-302. PubMed ID: 12548549 [Abstract] [Full Text] [Related]
18. Activation of phospholipase D activity in transforming growth factor-beta-induced cell growth inhibition. Zhou BH, Chen JS, Chai MQ, Zhao S, Liang J, Chen HH, Song JG. Cell Res; 2000 Jun 15; 10(2):139-49. PubMed ID: 10896175 [Abstract] [Full Text] [Related]
19. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells. Dong F, Wu HB, Hong J, Rechler MM. J Cell Physiol; 2002 Jan 15; 190(1):63-73. PubMed ID: 11807812 [Abstract] [Full Text] [Related]
20. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells. Miyafuji Y, Zhong X, Uchida I, Koi M, Hemmi H. J Cell Physiol; 2001 Jun 15; 187(3):356-64. PubMed ID: 11319759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]